ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 310547 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 310547; 2) Community: the network communities that were significantly associated with the response to NSC 310547; 3) Molecule: the relationships between components within communities and NSC 310547; 4) MDR: the compounds that were significantly associated with the NSC 310547.

NSC Compound Enrichment Correlation
NSC 749862 3-[2-(4-methoxyphenyl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine 0.00423163567577548 0.076741632
NSC 758965 CEPHARANTHINE 0.00423163567577548 0.24436827
NSC 761769 Null 0.00423163567577548 0.23417336
NSC 93135 OXYACANTHINE 0.00423163567577548 0.24985896
NSC 295642 Null 0.00423163567577551 0.39432529
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.00457614317494024 0.22897376
NSC 1393 4-APP 0.00457614317494024 0.28746467
NSC 318807 1H-Azepine-1-carbothioic acid, hexahydro-, [1-(2- pyridinyl)ethylidene]hydrazide 0.00457614317494024 0.56328192
NSC 625154 21-Oxabicyclo[16.2.1]heneicosane-4,9,14,18,20-pentaene, 3,6,8,11,13,16-hexaoxo-2,2,7,7,,12,12,17,17-octamethyl- 0.00457614317494024 0.39688713
NSC 625543 ANTINEOPLASTIC-625543 0.00457614317494024 0.55808855
Total:97  Current:13    [First] [Prev] [Next] [Last]